Dominguez Jr Jose C MD Brandon, FL - 33511

Dominguez Jr Jose C MD is categorized under Family Practice Doctors in Brandon, FL and active since 2000.

Dominguez Jr Jose C MD was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Jose Dominguez Jr at the company’s single location by writing to 539 Medical Oaks Avenue, Brandon, Florida FL 33511 or by phoning (813) 655-9736. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dominguez Jr Jose C MD
Contact Person: Jose Dominguez Jr
Address: 539 Medical Oaks Avenue, Brandon, Florida 33511
Phone Number: (813) 655-9736
Website Address: allergyasthmatampa.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Dominguez Jr Jose C MD was started in 2000 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Jose Dominguez Jr for inquiries that concern Dominguez Jr Jose C MD by calling the company number (813) 655-9736, as your correspondence is most welcome. Additionally, the physical location of the single location of Dominguez Jr Jose C MD can be found at the coordinates 27.92917,-82.29078 as well as the street address 539 Medical Oaks Avenue in Brandon, Florida 33511.

For its online presence, you may visit Dominguez Jr Jose C MD’s website at allergyasthmatampa.com and engage with its social media outlets through on Twitter and on Facebook.